A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is R$ 503,02, with a 24-hour trading volume of R$ 898,58M. The asset's market cap is R$ 1,55T, after moving -0.34% in the last day.
Tokenized AstraZeneca PLC is trading at R$ 504,26, with a tokenized market cap of R$ 3,78M and a 24-hour trading volume of R$ 357,83K. The tokenized asset has moved 0.22% in the past 24 hours.